首页 | 本学科首页   官方微博 | 高级检索  
检索        

血脂康胶囊对冠心病患者血管内皮功能及氧化还原态的影响
引用本文:黄彦生,王树人,智艳芳,孔沈燕,孙琳,吴彧,卢建敏,戴付敏.血脂康胶囊对冠心病患者血管内皮功能及氧化还原态的影响[J].中西医结合学报,2006,4(3):251-255.
作者姓名:黄彦生  王树人  智艳芳  孔沈燕  孙琳  吴彧  卢建敏  戴付敏
作者单位:1. 四川大学华西基础医学与法医学院病理生理学教研室,四川,成都,610041
2. 成都中医药大学,四川,成都,610075
3. 河南省人民医院二内科,河南,郑州,450003
基金项目:四川省科技厅重点科技资助项目(No.02SY029-123)C
摘    要:目的:探讨血脂康胶囊和普罗布考对冠心病患者的降脂作用及其对血管内皮功能、氧化还原态的影响。方法:112例冠心病患者,随机分为血脂康组(56例)和普罗布考组(56例)。治疗前及治疗8周后,检测2组患者血总胆固醇(total cholesterol,TC)、甘油三酯(triglycerides,TG)、低密度脂蛋白胆固醇(lowdensity lipoprotein cholesterol,LDL-C)、一氧化氮(nitric oxide,NO)、内皮-素1(endothelin-1,ET-1)、还原型谷胱甘肽(glutathione,GSH)和氧化型谷胱甘肽(oxidized glutathione,GSSG)的水平,并计算GSH/GSSG氧化还原电位。结果:血脂康组患者治疗后血TC、LDL-C和TG水平较治疗前降低,普罗布考组患者血TC、LDL-C水平较治疗前降低,差异均有统计学意义。血脂康组患者治疗后血ET-1、GSSG水平及GSH/GSSG氧化还原电位较治疗前降低,血GSH、NO水平及NO/ET-1、GSH/GSSG比值较治疗前升高,差异均有统计学意义。结论:血脂康胶囊和普罗布考对冠心病患者均有降脂作用。血脂康胶囊对血管内皮功能具有一定的保护作用,可使GSH/GSSG氧化还原态向还原方向偏移。

关 键 词:血脂康胶囊  冠心病  内皮素-1  一氧化氮  谷胱甘肽
文章编号:1672-1977(2006)03-0251-05
收稿时间:2006-01-04
修稿时间:2006年1月4日

Effects of Xuezhikang Capsules on vascular endothelial function and redox status in patients with coronary heart disease
Yan-Sheng HUANG,Shu-Ren WANG,Yan-Fang ZHI,Shen-Yan KONG,Lin SUN,Yu WU,Jian-Min LU,Fu-Min DAI.Effects of Xuezhikang Capsules on vascular endothelial function and redox status in patients with coronary heart disease[J].Journal of Chinese Integrative Medicine,2006,4(3):251-255.
Authors:Yan-Sheng HUANG  Shu-Ren WANG  Yan-Fang ZHI  Shen-Yan KONG  Lin SUN  Yu WU  Jian-Min LU  Fu-Min DAI
Institution:Department of Pathophysiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan Province 610041, China.
Abstract:Objective: To explore the effects of Xuezhikang Capsules(ZXKC) and probucol on blood lipids,vascular endothelial functions and redox status in patients with coronary heart disease.Methods: One hundred and twelve patients with coronary heart disease were randomly divided into XZKC-treated group and probucol-treated group,56 in each.Before and after 8-week treatment,the blood levels of total cholesterol(TC),triglycerides(TG),low density lipoprotein cholesterol(LDL-C),nitric oxide(NO),endothelin-1(ET-1),reduced glutathione(GSH) and oxidized glutathione(GSSG) were all measured in both groups.The GSH/GSSG redox potential(Eh) was calculated according to the Nernst equation.Results: In the XZKC-treated group,the blood levels of TC,LDL-C and TG were significantly decreased after 8-week treatment as compared with those before treatment.The blood levels of TC and LDL-C were also significantly decreased in the probucol-treated group as compared with those before treatment.In the XZKC-treated group,the blood levels of ET-1 and GSSG and the GSH/GSSG Eh after treatment were all significantly lower than those before treatment,whereas the blood levels of GSH and NO,the NO/ET-1 ratio,and the GSH/GSSG ratio after treatment were all significantly higher than those before treatment.Conclusion: The XZKC or probucol treatment can yield a significant decrease in blood lipids in patients with coronary heart disease.Furthermore,XZKC exerts effective protection on vascular endothelial function,and can make GSH/GSSG redox status shift towards deoxidation.
Keywords:Xuezhikang Capsules  coronary heart disease  nitric oxide  endothelin-1  glutathione
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号